HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing
dc.contributor.author | Richard, Jonathan | |
dc.contributor.author | Sindhu, S. | |
dc.contributor.author | Pham, T.N.Q | |
dc.contributor.author | Belzile, Jean-Philippe | |
dc.contributor.author | Cohen, Éric A. | |
dc.date.accessioned | 2010-12-19T20:32:12Z | |
dc.date.available | NO_RESTRICTION | en |
dc.date.available | 2010-12-19T20:32:12Z | |
dc.date.issued | 2010 | |
dc.identifier.uri | http://hdl.handle.net/1866/4481 | |
dc.description.sponsorship | JR is recipient of a Frederick Banting and Charles Best scholarship from the Canadian Institutes of Health Research (CIHR) while JPB is recipient of a CIHR studentship. EAC holds the Canada Research Chair in Human Retrovirology. This work was supported by grants from CIHR and the Fonds de recherche en santé du Québec AIDS network to EAC. | en |
dc.title | HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing | en |
dc.type | Article | en |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Institut de recherches cliniques de Montréal | fr |
dc.contributor.affiliation | Université de Montréal. Faculté de médecine. Département de microbiologie, infectiologie et immunologie | fr |
dc.identifier.doi | 10.1182/blood-2009-08-237370 | |
dcterms.abstract | HIV upregulates cell-surface expression of specific ligands for the activating NKG2D receptor, including ULBP-1, -2, -3, but not MICA or MICB, in infected cells both in vitro and in vivo. However, the viral factor(s) involved in NKG2D ligand expression still remains undefined. HIV-1 Vpr activates the DNA damage/stress-sensing ATR kinase and promotes G2 cell-cycle arrest, conditions known to upregulate NKG2D ligands. We report here that HIV-1 selectively induces cell-surface expression of ULBP-2 in primary CD4+ T-lymphocytes by a process that is Vpr-dependent. Importantly, Vpr enhanced the susceptibility of HIV-1-infected cells to NK cell-mediated killing. Strikingly, Vpr alone was sufficient to upregulate expression of all NKG2D ligands and thus promoted efficient NKG2D-dependent NK cell-mediated killing. Delivery of virion-associated Vpr via defective HIV-1 particles induced analogous biological effects in non-infected target cells, suggesting that Vpr may act similarly beyond infected cells. All these activities relied on Vpr ability to activate the ATR-mediated DNA damage/stress checkpoint. Overall, these results indicate that Vpr is a key determinant responsible for HIV-1-induced upregulation of NKG2D ligands and further suggest an immunomodulatory role for Vpr that may not only contribute to HIV-1-induced CD4+ T-lymphocyte depletion but may also take part in HIV-1-induced NK cell dysfunction. | en |
dcterms.language | eng | en |
UdeM.VersionRioxx | Version acceptée / Accepted Manuscript | |
oaire.citationTitle | Blood | |
oaire.citationVolume | 115 | |
oaire.citationIssue | 7 | |
oaire.citationStartPage | 1354 | |
oaire.citationEndPage | 1363 |
Files in this item
This item appears in the following Collection(s)
This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.